Expert Perspectives

Use the tool below to view all available Global Neurology Academy Series

SPECIAL REPORT: Expert Opinion on New MS Drug Approval
SPECIAL REPORT: Expert Opinion on New MS Drug Approval
Resources
SPECIAL REPORT: Expert Opinion on New MS Drug Approval
- Prof. Ralf Gold
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Resources
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Resources
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
The Diagnostic Challenges of Spinal Cord Lesions in MS
The Diagnostic Challenges of Spinal Cord Lesions in MS
CME/CE
The Diagnostic Challenges of Spinal Cord Lesions in MS
- Jiwon Oh, MD, PhD
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Resources
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Resources
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Reducing the Burden of MS Treatment
Reducing the Burden of MS Treatment
Resources
Reducing the Burden of MS Treatment
Multiple Sclerosis Physician Resources
Multiple Sclerosis Physician Resources
Resources
Multiple Sclerosis Physician Resources
Immunologic Effects on Metabolic Syndrome and MS
Immunologic Effects on Metabolic Syndrome and MS
Interviews
Immunologic Effects on Metabolic Syndrome and MS
Highlights from the MAGNIMS Consensus Guidelines
Highlights from the MAGNIMS Consensus Guidelines
Interviews
Highlights from the MAGNIMS Consensus Guidelines
Optimizing MS Treatment Options
Optimizing MS Treatment Options
Interviews
Optimizing MS Treatment Options
Current Landscape of MS Diagnosis/Prognosis
Current Landscape of MS Diagnosis/Prognosis
CME/CE
Current Landscape of MS Diagnosis/Prognosis
Determining an MS Patient's Long-Term Prognosis
Determining an MS Patient's Long-Term Prognosis
CME/CE
Determining an MS Patient's Long-Term Prognosis
The Value of Biomarkers in MS Patients
The Value of Biomarkers in MS Patients
Interviews
The Value of Biomarkers in MS Patients
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
CME/CE
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
Current and Future MS Treatment Options
Current and Future MS Treatment Options
CME/CE
Current and Future MS Treatment Options

Expert Perspectives

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

Expert Perspectives

Popular

Title

Share on ReachMD